HeartWare vote for US move

By Dylan Bushell-Embling
Wednesday, 17 September, 2008

Medical device company HeartWare [ASX: HTW] has received federal court approval to go ahead with shareholder meetings to vote on its plans to redomicile in the US.

Meetings are planned for October 22.

HeartWare has appointed BDO Kendalls Corporate Finance (QLD) to independently assess the proposed scheme. BDO has determined that the scheme is in the best interest of all stockholders.

Related News

Farm animals and aquaculture cryopreservation partnership announced

Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Content from other channels on our network

Siemens introduces industrial metaverse design environment

IFR predicts the top five global robotics trends for 2026

UNSW researchers find uses for textiles and other wastes

Queensland BESS project gets grid connection approval

Local defence manufacturing receives funding boost

Carbon-conversion technology creates chemicals for jet fuel

Novel energy storage system to decarbonise buildings

F-Gas Regulation: Turning necessity into opportunity

Tiny gold spheres could improve solar energy harvesting

Methane reduction trial uses nature-based supplement

Afnor acquires HACCP Australia and HACCP International

Solving the limitations for paper packaging with coating strategy

Packserv expands into the US with its packaging machinery

Keeping PEZ tablets rolling consistently with print upgrade

Food-grade upscaling line for 'new food' developments

All content Copyright © 2026 Westwick-Farrow Pty Ltd